Pharmaceuticals

Increasing Focus On Introducing The First Oral Cannabis Capsule Tailored For Chronic Pain Relief Is Playing A Role In Shaping The Nerve Growth Factor Market

May 1, 2026May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Nerve Growth Factor Market In 2026, And How Will Its Value Evolve By 2030?

The nerve growth factor market size has experienced strong growth in recent years. It is projected to increase from $1.19 billion in 2025 to $1.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. This historical growth can be linked to advances in neurobiology research, the clinical development of cenegermin, the rising prevalence of neurological disorders, the expansion of ophthalmology treatment adoption, and the growth of biologics manufacturing.

The nerve growth factor market is poised for significant expansion in the coming years, with forecasts showing it will achieve a size of $1.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This anticipated growth throughout the forecast period stems from factors such as the increasing prevalence of neurodegenerative diseases, the broadening scope of regenerative medicine programs, a rise in clinical trials dedicated to nerve repair, augmented funding for biologics R&D, and advancements in NGF delivery systems. Furthermore, prominent trends during this period involve intensified research into neuroregeneration therapies, a greater focus on addressing neurodegenerative diseases, the expansion of recombinant protein therapeutics, increasing clinical utility in ophthalmic disorders, and enhanced investment in nerve repair technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22070&type=smp

Which Primary Drivers Are Impacting The Nerve Growth Factor Market Growth?

The rising incidence of neurological conditions is anticipated to drive the expansion of the nerve growth factor market in the future. These disorders are defined as medical ailments impacting the brain, spinal cord, and nerves, stemming from structural, biochemical, or electrical irregularities. The heightened occurrence of neurological disorders is attributable to an aging populace and advancements in diagnostic methods, which improve the detection and reporting of these conditions, resulting in greater documented rates of incidence. Nerve growth factor (NGF) is vital for the upkeep, survival, and renewal of neurons, thereby becoming a significant element in tackling the widespread nature of neurological disorders through fostering neural repair and potentially impeding disease advancement. As an illustration, in September 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, forecasted that dementia (a neurological disorder) cases in Australia would increase from approximately 411,100 in 2023 to 849,300 by 2058. Consequently, the growing frequency of neurological disorders is propelling the expansion of the nerve growth factor market.

What Are The Main Segments Within The Nerve Growth Factor Market Segment Structure?

The nerve growth factor market covered in this report is segmented –

1) By Type: Alpha-Nerve Growth Factor (NGF), Beta-Nerve Growth Factor (NGF), Gamma-Nerve Growth Factor (NGF), Other Types

2) By Agents: Cenegermin, Other Agents

3) By Indication: Neurodegenerative Disorders, Spinal Cord Injuries, Eye Disorders, Epithelial Diseases, Tissue Healing, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Alpha-Nerve Growth Factor (a-NGF): Natural Alpha-NGF, Recombinant Alpha-NGF, Synthetic Alpha-NGF, Alpha-NGF For Research Applications

2) By Beta-Nerve Growth Factor (ß-NGF): Human Beta-NGF, Animal-Derived Beta-NGF, Recombinant Beta-NGF, Therapeutic Beta-NGF, Research-Grade Beta-NGF

3) By Gamma-Nerve Growth Factor (?-NGF): Natural Gamma-NGF, Recombinant Gamma-NGF, Synthetic Gamma-NGF, Gamma-NGF for Neurodegenerative Research

4) By Other Types: Hybrid NGF Molecules, NGF Mimetics, NGF Gene Therapy-Based Products, NGF-Infused Biomaterials

What Trends Are Transforming The Nerve Growth Factor Market?

Leading companies in the nerve growth factor market are concentrating on developing biologic therapies that target NGF, particularly anti-NGF monoclonal antibodies, which are formulated to suppress NGF activity and mitigate chronic pain. An anti-NGF monoclonal antibody operates by binding to nerve growth factor, thereby preventing its receptors from being activated. This action contributes to reducing pain signaling and inflammatory responses in individuals afflicted with degenerative or neuropathic conditions. For example, in May 2023, Jiangsu Hengrui Pharmaceuticals, a China-based biopharmaceutical company, unveiled SHR-1314, a cutting-edge anti-NGF monoclonal antibody that has been registered for clinical evaluation in patients with osteoarthritis-related pain. This therapy boasts a highly selective binding profile that decreases NGF-mediated sensitization, along with a long serum half-life that facilitates less frequent dosing, with the goal of providing sustained pain relief for people living with chronic joint disease.

Who Are The Companies Participating In The Nerve Growth Factor Market?

Major companies operating in the nerve growth factor market are Dompé farmaceutici S.p.A., Regeneron Pharmaceuticals Inc., Mimetogen Pharmaceuticals, MimeTech Srl, Herantis Pharma, PainCeptor Pharma, Beike Biotechnology, Akeso Inc., Promega Corporation, Enzo Life Sciences Inc., Alomone Labs, Prospec-Tany Technogene Ltd., CUSABIO Technology LLC, Genexis Biotech Pvt. Ltd., Staidson Beijing BioPharmaceuticals, Biomol GmbH, Sino Biological Inc., PeproTech Inc., Abcam plc, Creative BioMart Inc.

Get The Full Nerve Growth Factor Market Report:

https://www.thebusinessresearchcompany.com/report/nerve-growth-factor-global-market-report

Which Region Is The Top Contributor To The Nerve Growth Factor Market By Share?

Asia-Pacific was the largest region in the nerve growth factor market in 2025. The regions covered in the nerve growth factor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Nerve Growth Factor Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/nerve-growth-factor-global-market-report

Browse Through More Reports Similar to the Global Nerve Growth Factor Market 2026, By The Business Research Company

Nerve Repair And Regenerative Market Report 2026

https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report

Neuromodulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Peripheral Nerve Injuries Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-nerve-injuries-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795